David Linetsky Phreesia, Inc. (PHR) insider trading activity

David Linetsky is SVP, Life Sciences of Phreesia, Inc.. Currently has a direct ownership of 203,318 shares of PHR, which is worth approximately $4.8 Million. The most recent transaction as insider was on Aug 26, 2021, when has been sold 800 shares (Common Stock) at a price of $2.55 per share, resulting in proceeds of $2,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 203K

0.35% 3M change

6.35% 12M change

Total Value Held $4.8 Million

David Linetsky Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 26 2021	BUY Exercise of conversion of derivative security	$2,040 $2.55 p/Share	800 Added 0.56%	141,188 Common Stock
Aug 25 2021	SELL Open market or private sale	$35,020 $70.04 p/Share	500 Reduced 0.35%	140,388 Common Stock
Aug 25 2021	BUY Exercise of conversion of derivative security	$1,275 $2.55 p/Share	500 Added 0.35%	140,888 Common Stock
May 04 2021	BUY Exercise of conversion of derivative security	$65,534 $1.44 p/Share	45,510 Added 24.48%	140,388 Common Stock
Mar 16 2021	SELL Open market or private sale	$94,917 $60.15 p/Share	1,578 Reduced 1.68%	92,580 Common Stock
Mar 15 2021	SELL Open market or private sale	$2,975,825 $61.38 p/Share	48,482 Reduced 33.99%	94,158 Common Stock
Jan 20 2021	SELL Open market or private sale	$447,103 $65.5 p/Share	6,826 Reduced 4.57%	142,640 Common Stock
Jan 19 2021	SELL Open market or private sale	$330,142 $64.28 p/Share	5,136 Reduced 3.32%	149,466 Common Stock
Jan 17 2021	SELL Payment of exercise price or tax liability	$17,440 $62.96 p/Share	277 Reduced 0.18%	154,602 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$112,510 $62.96 p/Share	1,787 Reduced 1.14%	154,879 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	28,589 Added 15.43%	156,666 Common Stock
Oct 01 2020	SELL Open market or private sale	$140,488 $31.38 p/Share	4,477 Reduced 3.38%	128,077 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$6,486 $4.71 p/Share	1,377 Added 1.03%	132,554 Common Stock

David Linetsky

SVP, Life Sciences

Raleigh, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHR shares.

Notify only if

Value

Insider Trading

Get notified when an Phreesia, Inc. insider buys or sells PHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Phreesia, Inc.

Track Activities on PHR

Account